125 related articles for article (PubMed ID: 7449742)
1. Estrogenic effects of nafoxidine on ovarian-dependent and independent mammary tumor lines in the mouse.
Watson CS; Medina D; Clark JH
Endocrinology; 1981 Feb; 108(2):668-72. PubMed ID: 7449742
[TBL] [Abstract][Full Text] [Related]
2. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
Attardi B; Palumbo LA
Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
[TBL] [Abstract][Full Text] [Related]
3. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the estradiol-induced luteinizing hormone surge by progesterone or antiestrogens: effects on pituitary gonadotropin-releasing hormone receptors.
Attardi B; Happe HK
Endocrinology; 1986 Jul; 119(1):274-83. PubMed ID: 3013589
[TBL] [Abstract][Full Text] [Related]
5. Characterization of progesterone receptors, estrogen receptors, and estrogen (type II)-binding sites in the hormone-independent variant of the MXT-3590 mouse mammary tumor.
Watson CS; Medina D; Clark JH
Endocrinology; 1980 Nov; 107(5):1432-7. PubMed ID: 7428677
[TBL] [Abstract][Full Text] [Related]
6. Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells.
Horwitz KB; Aiginger P; Kuttenn F; McGuire WL
Endocrinology; 1981 May; 108(5):1703-9. PubMed ID: 7194178
[No Abstract] [Full Text] [Related]
7. Disparate effects of triphenylethylene antiestrogens on estrogen and progestin biosyntheses by cultured rat granulosa cells.
Welsh TH; Jia XC; Jones PB; Zhuang LZ; Hsueh AJ
Endocrinology; 1984 Oct; 115(4):1275-82. PubMed ID: 6434288
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
Katzenellenbogen BS; Ferguson ER
Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
[TBL] [Abstract][Full Text] [Related]
9. Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.
Horwitz KB; Mockus MB; Lessey BA
Cell; 1982 Mar; 28(3):633-42. PubMed ID: 7200400
[TBL] [Abstract][Full Text] [Related]
10. Female steroid hormones and lipoprotein synthesis in the cockerel: effects of progesterone and nafoxidine on the estrogenic stimulation of very low density lipoproteins (VLDL) synthesis.
Chan L; Jackson RL; Means AR
Endocrinology; 1977 Jun; 100(6):1636-43. PubMed ID: 192542
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory and inhibitory effects of estrogen and antiestrogen on uterine cell division.
Mukku VR; Kirkland JL; Hardy M; Stancel GM
Endocrinology; 1981 Oct; 109(4):1005-10. PubMed ID: 7285857
[TBL] [Abstract][Full Text] [Related]
12. Characterization and estrogen stimulation of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary tumor line.
Watson CS; Medina D; Clark JH
Cancer Res; 1979 Oct; 39(10):4098-104. PubMed ID: 476646
[No Abstract] [Full Text] [Related]
13. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.
Eckert RL; Mullick A; Rorke EA; Katzenellenbogen BS
Endocrinology; 1984 Feb; 114(2):629-37. PubMed ID: 6690295
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
Ferguson ER; Katzenellenbogen BS
Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-induced progesterone receptor in the Syrian hamster kidney. I. Modulation by antiestrogens and androgens.
Li SA; Li JJ
Endocrinology; 1978 Dec; 103(6):2119-28. PubMed ID: 748036
[No Abstract] [Full Text] [Related]
16. Human breast cancer: biologically active estrogen receptor in the absence of estrogen?
Zava DT; Chamness GC; Horwitz KB; McGuire WL
Science; 1977 May; 196(4290):663-4. PubMed ID: 193182
[TBL] [Abstract][Full Text] [Related]
17. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen.
Horwitz KB; Koseki Y; McGuire WL
Endocrinology; 1978 Nov; 103(5):1742-51. PubMed ID: 748014
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
Gardner RM; Kirkland JL; Stancel GM
Endocrinology; 1978 Nov; 103(5):1583-9. PubMed ID: 748005
[TBL] [Abstract][Full Text] [Related]
19. Nafoxidine administered to newborn female GR mice arrests the development of their mammary glands.
Strum JM
Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 42(2):227-33. PubMed ID: 6133394
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the action of estradiol and that of the antiestrogen U 11-100 A on the induction in the rat uterus of a specific protein (the induced protein).
Mairesse N; Galand P
Endocrinology; 1979 Nov; 105(5):1248-53. PubMed ID: 488011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
